Boston, MA — September 14, 2016
Event: Boston Biotech Conferences Anti-Infectives Rx Conference
L.E.K. Managing Director Jonathan Kfoury will moderate ‘Tackling Resistance: The Promise and The Challenge’ panel, with panelists: Eliav Barr, Merck; Nicholas Benedict, Allecra Therapeutics; Cara Cassino ContraFect; Evan Jones, OpGen; and Scott Salka, AmpliPhi Biosciences.
September 21, 2016
Joseph B. Martin Conference Center at Harvard Medical School
77 Avenue Louis Pasteur, Boston, MA
Time: 9:00 — 9:30 a.m.
About Jonathan Kfoury:
Jonathan Kfoury is a Managing Director and Partner in L.E.K. Consulting’s San Francisco office, focused on biopharmaceuticals, medical technology and life sciences. He joined the firm in 2006, and since that time has led an extensive set of engagements with global biopharmaceutical, medical technology and diagnostic clients across human health, animal health and agribusiness markets. Jonathan advises clients on commercial strategy and life-cycle management for in-line products, market access and commercialization planning for pipeline assets, and growth / partnering strategy. With an operating background in both Clinical and Business Development at specialty biopharmaceutical companies, Kfoury brings a hands-on understanding of internal decision-making needs to his advisory work with clients.
With a sincere interest in both the public health and business challenges associated with the space, Jonathan has consulted, published, and spoken widely in recent years on topics related to antibiotic resistance, development, commercialization, and strategy.
Prior to joining L.E.K., Jonathan was a Business Development executive for Acusphere and Purdue Pharma, and manager of global Clinical Development for Cubist Pharmaceuticals’ (now Merck) blockbuster antibiotic Cubicin® - the most successful IV antibiotic launched in US history. In addition to global management training at INSEAD, he earned an S.M. in Health Policy & Management from Harvard University, and graduated from Trinity College with a Bachelor of Science degree in Neuroscience.
About Anti-Infectives Rx and Boston Biotech Conferences
The Boston Biotech Conferences (BBC) are exclusive, thought-leader forums for senior biopharma executives. Each conference is highly interactive and co-hosted by healthcare industry leaders to foster discussions and facilitate information-sharing, networking and corporate development within the biopharma community.
The Anti-Infectives Rx meeting is an off-the-record forum featuring discussion panels from industry CEOs, life science leaders, key academics and investors. It focuses on issues facing the development of anti-infective, antiviral, and antibacterial therapies, and discusses regulatory issues, sustainability, partnering, as well as microbiome and immunotherapy as the new wave of anti-infectives.
About L.E.K. Consulting:
L.E.K. Consulting is a global management consulting firm that uses deep industry expertise and rigorous analysis to help business leaders achieve practical results with real impact. We are uncompromising in our approach to helping clients consistently make better decisions, deliver improved business performance and create greater shareholder returns. The firm advises and supports global companies that are leaders in their industries — including the largest private and public sector organizations, private equity firms and emerging entrepreneurial businesses. Founded more than 30 years ago, L.E.K. employs more than 1,200 professionals across the Americas, Asia-Pacific and Europe. For more information, go to www.lek.com.